28 The cost-effectiveness ratio in the analysis of health care programs

Handbook of Statistics

Volumn 18, Issue , 2000, Pages 841-869

  Gardiner, Joseph C ^a   Bradley, Cathy J ^a   Huebner, Marianne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350336589     PISSN: 01697161     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0169-7161(00)18030-7     Document Type: Review

References (75)

1. Adams M.E., McCall N.T., Gray D., Orza M.J., and Chalmers T.C. Economic analyses in randomized control trials. Med. Care 30 (1992) 231-243
2. Andersen P.K., Borgan Ø., Gill R.D., and Keiding N. Statistical Models based on Counting Processes (1993), Springer-Verlag, Dordrecht
3. Beck R.J., and Pauker S.G. The Markov process in medical prognosis. Med. Decis. Making 3 (1983) 419-458
4. Blackmore C.C., and Magid D.J. Methodologic evaluation of the radiology cost-effectiveness literature. Radiol. 203 (1997) 87-91
5. Blackmore C.C., and Magid D.J. Economic analyses in obstetrics and gynecology: A methodologic evaluation of the literature. Obst. Gynecol. 91 (1998) 472-478
6. Briggs A., and Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Economics 2 (1998) 723-740
7. Briggs A.H., and Gray A.M. Power and sample size calculations for stochastic cost-effectiveness analyses. Med. Decis. Making 18 (1998) S81-S92
8. Briggs A.H., Wonderling D.E., and Mooney C.Z. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics 6 (1997) 327-340
9. Chaudhary M.A., and Stearns S.C. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Stat. Med. 15 (1996) 1447-1458
10. Cole B.F., Gelber R.D., and Anderson K.M. Parametric approaches to quality-adjusted survival analysis. Biometrics 50 (1994) 621-631
11. Cole B.F., Gelber R.D., and Goldhirsch A. Cox regression models for quality adjusted survival analysis. Statist. Med. 12 (1993) 975-987
12. Davis M.H.A. Markov Models and Optimization (1994), Chapman-Hall, New York
13. Detsky A.S., and Naglie I.G. A clinician's guide to cost-effectiveness analysis. Ann. Int. Med 113 2 (1990) 147-154
14. Doubilet P., Begg C.B., Weinstein M.C., Braun P., and McNeil B.J. Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach. Med. Decis. Making 5 (1985) 157-177
15. Dranove D. Measuring costs. In: Sloan F. (Ed). Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and Other Med. Technologies (1995), Cambridge University Press, New York 61-75
16. Drummond M., and Davis L. Economic analysis alongside clinical trials: Revisiting the methodological issues. Int. J. Technol. Assess. Health Care 7 (1991) 561-573
17. Drummond M.F., O'Brien B., Stoddart G.L., and Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes. Second edition (1997), Oxford University Press, New York
18. Dudley R.A., Harrell F.E., Smith R.L., Mark D.B., Califf R.M., Glower D., Lipscomb J., and Hlatky M. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass surgery. J. Clin. Epdemiol. 46 (1993) 261-271
19. Efron B. More efficient bootstrap computations. J. Amer. Statist. Assoc. 85 (1990) 79-89
20. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall
21. Eisenberg J. Clinical economics: A guide to the economic analysis of clinical practices. JAMA 262 (1989) 2879-2886
22. Evers S.M.A.A., van Wijk A.S., and Ament A.J.H.A. Economic evaluation of mental health care interventions: A review. Health Economics 6 (1997) 161-177
23. Fieller E.C. Some problems in interval estimation. J. Roy. Statist. Soc. B. 16 (1954) 175-185
24. Gafni A., and Birch S. Guidelines for the adoption of new technologies: A prescription for uncontrolled growth in expenditures and how to avoid the problem. Can. Med. Assoc. J. 148 6 (1993) 913-917
25. In press. Gardiner J.C., Huebner M., Jetton J., and Bradley C.J. Power and sample size assessments for tests of hypotheses on cost-effectiveness ratios. Health Economics (2000)
26. Submitted. Gardiner J.C., Bradley C.J., and Huebner M. On parametric confidence intervals for the cost-effectiveness ratio (1999)
27. Gardiner J.C., Hogan A., Holmes-Rovner M., Rovner D., Griffith L., and Kupersmith J. Confidence intervals for cost-effectiveness ratios. Med. Decis. Making 15 (1995) 254-263
28. Submitted. Gardiner J.C., Indurkhya A., and Luo Z. The performance of estimation procedures for the cost-effectiveness ratio (1999)
29. Gardiner J.C., Holmes-Rovner M., Goddeeris J., Rovner D., and Kupersmith J. Covariate adjusted cost-effectiveness ratios. J. Statist. Plann. Inference 75 2 (1999) 291-304
30. Glasziou P.P., Simes R.J., and Gelber R.D. Quality adjusted survival analysis. Statist. Med. 9 (1990) 1259-1276
31. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York
32. In: Haddix A., Teutsch S., Schaffer P., and Duñet D. (Eds). Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation (1996), Oxford University Press, New York
33. Hunink M.G., Bult J.R., De Vries J., and Weinstein M.C. Uncertainty in decision models analyzing cost-effectiveness: The joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med. Decis. Making 18 (1998) 337-346
34. Hwang J.S., Tsauo J.Y., and Wang J.D. Estimation of expected quality adjusted survival by cross-sectional sampling. Statist. Med. 15 (1996) 93-102
35. Johannesson M. The relationship between cost-effectiveness analysis and cost-benefit analysis. Soc. Sci. Med. 41 4 (1995) 483-489
36. Johannesson M., and Meltzer D. Some reflections on cost-effectiveness analysis. Health Economics 7 (1998) 1-7
37. Johannesson M., Jönsson B., and Karlsson G. Outcome measurement in economic evaluation. Health Economics 5 (1996) 279-296
38. Johannesson M., and Weinstein M.C. On the decision rules of cost-effectiveness analysis. J. Health Economics 12 (1993) 459-467
39. Kamlet M.S. A Framework for Cost-Utility Analysis of Government Health Care Programs: The Comparative Benefits Modeling Project (1992), US Department of Health and Human Services, US Public Health Service, Washington, DC
40. Karlsson G., and Johannesson M. Decision rules for cost-effectiveness analysis. Pharmaco-Economics 9 (1996) 113-120
41. Klevit H.D., Bates A.C., Castanares T., Kirk E.P., Sipes-Metzler P.R., and Wolpat R. Prioritization of health care services: A progress report by the Oregon Health Services Commission. Arch. Intern. Med. 151 (1991) 912-916
42. Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., and Gardiner J. Cost effectiveness analysis in heart disease. Part I, General Principles. Prog. Cardiovas. Dis. 37 3 (1994) 161-184
43. Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., and Gardiner J. Cost effectiveness analysis in heart disease. Part II, Preventive Therapies. Prog. Cardiovas. Dis. 37 4 (1995) 243-271
44. Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., and Gardiner J. Cost effectiveness analysis in heart disease. Part III, Ischemia, Congestive Heart Failure, and Arrhythmias. Prog. Cardiovas. Dis. 37 5 (1995) 307-346
45. Lafata J.E., Koch G.G., and Ward R.E. Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics. Med. Care 34 (1996) DS136-DS145
46. Laska E., Meisner M., and Siegel C.S. Statistical inference for cost-effectiveness ratios. Health Economics 6 (1997) 229-242
47. Laska E., Meisner M., and Siegel C.S. Power and sample size in cost-effectiveness analysis. Med. Decis. Making 19 (1999) 339-343
48. Laska E.M., Meisner M., Siegel C., and Stinnett A.A. Ratio-based and net benefits-based approaches to health care resource allocation: Proofs of optimality and equivalence. Health Economics 8 2 (1999) 171-174
49. Laupacis A., Feeney D., Detsky A.S., and Tugwell P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can. Med. Assoc. J. 146 4 (1992) 473-481
50. Lipcomb J., Ancukiewicz M., Parmigiani G., Hasselbald V., Samsa G., and Matchar D.B. Predicting the cost of illness. A comparison of alternative models applied to stroke. Med. Decis. Making 18 (1998) S39-S56
51. Mandelblatt J.S., Fryback D.G., Weinstein M.C., Russell L.B., and Gold M.R. Assessing the effectiveness of health interventions for cost-effectiveness analysis. J. Gen. Intern. Med. 12 (1997) 551-558
52. Mullahy J. What you don't know cant't hurt you? Statistical issues and standards for medical technology evaluation. Med. Care 34 12 (1996) DS124-DS135
53. Mullahy J., and Manning W. Statistical issues in cost-effectiveness analyses. In: Sloan F. (Ed). Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and Other Med. Technologies (1995), Cambridge University Press 149-184
54. O'Brien B.J., Drummond M.F., Labelle R.J., and Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med. Care 32 2 (1994) 150-163
55. Pettiti D. Meta-analysis, decision-analysis, and cost-effectiveness analysis (1994), Oxford University Press, New York
56. Phelps C.E., and Mushlin A.I. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int. J. Technol. Assess. Health Care 7 1 (1991) 12-21
57. Pr{high symbol}stgaard J. Nonparametric estimation of actuarial values. Scand. Actuar. J. 2 (1991) 129-143
58. Sacristán J.A., Day S.J., Navarro O., Ramos J., and Hernandez J.M. Use of confidence intervals and sample size calculations in health economic studies. Ann. Pharmacother. 29 (1995) 719-725
59. Shen L.Z., Pulkstenis E., and Hoseyni M. Estimation of mean quality adjusted survival time. Statist. Med. 18 (1999) 1541-1554
60. Siegel C.S., Laska E., and Meisner M. Statistical methods for cost-effectiveness analyses. Controlled Clin. Trials 17 (1996) 387-406
61. In: Sloan F. (Ed). Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies (1995), Cambridge University Press, Oxford
62. Sonnenberg F.A., and Beck R.J. Markov models in medical decision making: A practical guide. Med. Decis. Making. 13 4 (1993) 322-338
63. Stinnett A.A. Adjusting for bias in C/E ratio estimates. Health Economics 5 (1996) 470-472
64. Stinnett A.A., and Mullahy J. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decis. Making 18 (1998) S68-S80
65. Stinnett A.A., and Paltiel A.D. Mathematical programming for the efficient allocation of health care resources. J. Health Economics 15 (1996) 641-653
66. Tambour M., and Zethraeus N. Bootstrap confidence intervals for cost-effectiveness ratios: Some simulation results. Health Economics 7 (1998) 143-147
67. Tambour M., Zethraeus N., and Johannesson M. A note on confidence intervals in cost-effectiveness analysis. Int. J. Technol. Assess. Health Care 14 3 (1998) 467-471
68. In: Tolley G., Kenkel D., and Fabian R. (Eds). Valuing Health for Policy: An Economic Approach (1994), Chicago University Press, New York
69. van Hout B.A., Al M.J., Gordon G.S., and Rutten F.F.H. Cost, effects and C/E ratios alongside a clinical trial. Health Economics 3 (1994) 309-319
70. Wakker P., and Klassen M.P. Confidence intervals for cost/effectiveness ratios. Health Economics 4 (1995) 373-381
71. Weinstein M., and Stason W. Foundations of cost-effectiveness analysis for the health and medical practices. NEJM 296 10 (1977) 716-721
72. Weinstein M.C. From cost-effectiveness ratios to resource allocation: where do we draw the line?. In: Sloan F. (Ed). Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and Other Med. Technologies (1995), Cambridge University Press 77-98
73. Weinstein M.C., and Zeckhauser R.J. Critical ratios and efficient allocation. J. Pub. Economics 2 2 (1972) 147-157
74. Willan A.R., and O'Brien B.J. Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem. Health Economics 5 (1996) 297-305
75. Zhao H., and Tsiatis A.A. A consistent estimator for the distribution of quality adjusted survival time. Biometrika 84 2 (1997) 339-348